Brief: Imricor Medical Systems, Inc Submits Third PMA Module To The US FDA For Review
11/06/2026 02:28
BRIEF-Imricor Medical Systems, Inc Submits Third PMA Module To The US FDA For Review June 11 (Reuters) - Imricor Medical Systems, Inc IMR.AX:
SUBMISSION OF THE THIRD PMA MODULE TO THE US FDA FOR REVIEW
SUBMISSION INCLUDES VISION-MR ABLATION CATHETER 2, RF-5000 GENERATOR, RF-5000 TUBING SET
Further company coverage: IMR.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Imricor Medical Systems,
See all newsBrief: Imricor Medical Systems, Inc Submits Third PMA Module To The US FDA For Review
Brief: Imricor Medical Systems Granted ASX Waiver From Listing Rules Effective 26 May
Australia's Imricor Medical Systems slips on discounted placement
Brief: Imricor Medical Systems To Raise A$60 Mln At A$1.85 Per Share
Australia's Imricor rises on seeking FDA nod for product expansion in U.S.